Bio-cest Company Profile

13:01 EDT 25th September 2018 | BioPortfolio

The driving force behind the biotechnology industry in Newfoundland and Labrador is Bio-cest, a division of the OENES Group, the commercialization arm of University. Bio-cest is a network of over 50 members from business, government and academic institutions who are actively involved in and strongly support the growth of the biotechnology industry in Newfoundland and Labrador.
Newfoundland and Labrador is becoming a world leader in marine biotechnology and Bio-cest is playing a key role. With world-class facilities and a commitment to applied research and development, Newfoundland and Labrador is fostering academic excellence and building an environment where innovative companies grow and profit.

News Articles [28 Associated News Articles listed on BioPortfolio]

Correction of a release from 28.03.2018, 13:43 CET/CEST - Correction of a release from 28.03.2018, 11:03 CET/CEST - MOLOGEN AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

MOLOGEN AG 28.03.2018 / 14:56 Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ...

Caterpillar Inc.: Files Form 10-Q

Dow Jones received a payment from EQS/DGAP to publish this press release. Caterpillar Inc. Caterpillar Inc.: Files Form 10-Q 10-Aug-2018 / 17:13 CET/CEST Dissemination of a French Regulatory News,...

MorphoSys AG: MorphoSys to Host Q1 2018 Conference Call on May 3, 2018

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 25, 2018 / MorphoSys AG (FSE: MOR) (XETRA: MOR) (OTC PINK: MPSYY) will publish its first three months' 2018 results on May 2nd, 2018 at 10:00 p.m. CEST ...

PCI Biotech: Invitation to first quarter 2018 presentation

Oslo,Norway, 2 May 2018 - PCI Biotech invites to a presentation of the company's first quarter 2018 report on Tuesday 8 May 2018 at Oslo Cancer Cluster Innovation Park. Time: Tues...

UCB Announces Briviact (brivaracetam) Now Approved by FDA to Treat Partial-Onset (Focal) Seizures in Pediatric Epilepsy Patients

Atlanta, Georgia (U.S.) & Brussels (Belgium), 0700 CEST, 14 May, 2018: UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) ...

UCB Announces the Approval of Cimzia (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis

Brussels, Belgium – 28th May, 07:00 CEST – UCB announced today that the U.S. Food and Drug Administration (FDA) has approved extending the label for Cimzia (certolizumab pegol) to include a new in...

elexxion AG: Termination of Executive Board Membership

elexxion AG / Key word(s): Change of Personnel elexxion AG: Termination of Executive Board Membership 15-March-2018 / 17:45 CET/CEST Disclosure of an inside information acc. to Article 17 MAR ...

CORRECTING and REPLACING: Advicenne to Host a Conference Call on September 12, 2018 at 6 PM to Comment Its Recent Developments

Regulatory News: This replaces the announcement made at 06:45 pm CEST on 09/11/2018 due to the following corrections: correction in the title. Advicenne t...

Drugs and Medications [0 Results]


PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

Molecular basis for CesT recognition of type III secretion effectors in enteropathogenic Escherichia coli.

Enteropathogenic Escherichia coli (EPEC) use a needle-like injection apparatus known as the type III secretion system (T3SS) to deliver protein effectors into host cells. Effector translocation is hig...

Exploring methods to expedite the recording of CEST datasets using selective pulse excitation.

Chemical Exchange Saturation Transfer (CEST) has emerged as a powerful tool for studies of biomolecular conformational exchange involving the interconversion between a major, visible conformer and one...

Robust motion correction in CEST imaging exploiting low-rank approximation of the z-spectrum.

To introduce and evaluate an image registration technique for robust quantification of CEST acquisitions corrupted by motion.

Chemical exchange saturation transfer MRI contrast in the human brain at 9.4 T.

The high chemical shift separation at 9.4 T allows for selective saturation of proton pools in exchange with water protons. For the first time, highly selective and comprehensive chemical exchange s...

Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI).

To introduce a new pH-sensitive and oxygen-sensitive MRI technique using amine proton CEST echo spin-and-gradient echo (SAGE) EPI (CEST-SAGE-EPI).

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Brain Glioma Registry Combining Clinical and Imaging Information

This registry aims to collect clinical and radiologic information including detailed clinical, conventional MR and advanced MR imaging data of patients with brain gliomas. Advanced MR imag...

MRI and Metabolomics Biomarkers for Uterine Malignancy

The aims of this project are: (1) To establish a research platform in order to integrate multiparametric imaging and metabolomics data for uterine malignancy. (2) Identify potential surrog...

Companies [1 Associated Companies listed on BioPortfolio]


The driving force behind the biotechnology industry in Newfoundland and Labrador is Bio-cest, a division of the OENES Group, the commercialization arm of University. Bio-cest is a network of over 50 m...

More Information about "Bio-cest" on BioPortfolio

We have published hundreds of Bio-cest news stories on BioPortfolio along with dozens of Bio-cest Clinical Trials and PubMed Articles about Bio-cest for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bio-cest Companies in our database. You can also find out about relevant Bio-cest Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record